Related Experiment Video
Updated: Jul 25, 2025

Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery
Published on: February 10, 2023
Defining Biliary Hyperkinesia and the Role of Cholecystectomy
Akash Kartik1, Irving A Jorge2, Christopher Webb2
1From the Department of Surgery, Tulane University, New Orleans, LA (Kartik).
Insights
An ejection fraction (EF) cutoff of 81% on gallbladder scans may indicate biliary hyperkinesia. Cholecystectomy is recommended for patients with biliary symptoms and an EF above 81% for pain resolution.
Area of Science:
- Gastroenterology
- Hepatobiliary Surgery
Background:
- Functional gallbladder disorder is often diagnosed by biliary colic and low gallbladder ejection fraction (EF) on cholescintigraphy.
- Biliary hyperkinesia, a type of functional gallbladder disorder, has an unclear definition and treatment role for cholecystectomy.
Purpose of the Study:
- To determine the optimal ejection fraction (EF) cutoff for predicting symptom resolution after cholecystectomy in patients with biliary hyperkinesia.
- To establish a diagnostic criterion for biliary hyperkinesia.
Main Methods:
- Retrospective review of patients undergoing cholecystokinin-stimulated cholescintigraphy and cholecystectomy (2007-2020).
- Analysis included patients aged 18+ with biliary symptoms, EF >50%, and no acute cholecystitis or cholelithiasis.
- Receiver operating characteristics curve analysis identified the optimal EF cutoff for predicting symptom resolution.
Main Results:
- 1,596 patients had EF ≥50%, with 141 (8.8%) undergoing cholecystectomy.
- An EF cutoff of 81% significantly predicted pain resolution post-cholecystectomy (78.2% vs. 60.0%, p=0.03).
- Chronic cholecystitis was found in 61.7% of patients on final pathology.
Conclusions:
- An EF of 81% is proposed as the upper limit of normal gallbladder EF.
- Patients with biliary symptoms and EF >81% without other biliary disease evidence may have biliary hyperkinesia.
- Cholecystectomy is recommended for patients diagnosed with biliary hyperkinesia based on these findings.
Background:
Functional gallbladder disorder is most commonly defined by biliary colic and low ejection fraction (EF) on cholescintigraphy. Biliary hyperkinesia is a controversial type of functional gallbladder disorder, and its definition and the role of cholecystectomy in treating functional gallbladder disorder remains unclear.
Study Design:
We conducted a retrospective review of patients who underwent cholecystokinin-stimulated cholescintigraphy and cholecystectomy at 3 Mayo Clinic sites between 2007 and 2020. Eligible patients were 18 years or older, presented with symptoms of biliary disease, had an EF greater than 50%, underwent cholecystectomy, and had no evidence of acute cholecystitis or cholelithiasis on imaging. We used receiver operating characteristics curve analysis to identify the optimal cutoff value that predicted symptom resolution within 30 days of cholecystectomy.
Results:
A total of 2,929 cholecystokinin-stimulated cholescintigraphy scans were performed during the study period; the average EF was 67.5% and the median EF was 77%. Analyzing those with EFs greater than or equal to 50% yielded 1,596 patients with 141 (8.8%) going on to have cholecystectomy. No significant differences were found in age, sex, BMI, final pathology between patients with and without pain resolution. Using a cutoff EF of 81% was significantly associated with pain resolution after cholecystectomy (78.2% for EF greater than or equal to 81% vs 60.0% for EF less than 81%, p = 0.03). Chronic cholecystitis was found in 61.7% of the patients on final pathology.
Conclusions:
We determined that an EF cutoff of 81% is a reasonable upper limit of normal gallbladder EF. Patients with biliary symptoms and an EF greater than 81% but no evidence of biliary disease on ultrasound or scintigraphy can be classified as having biliary hyperkinesia. Based on our findings, we recommend cholecystectomy for this patient population.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Hepatic Drug Excretion: Influencing Factors
Endoscopic Procedures V: ERCP
Patient...
Acute Pancreatitis II: Clinical Manifestations and Management
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Chronic Pancreatitis II: Collaborative Care
Assessment:

